ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 192 filers reported holding ARCUS BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $30,436,014 | 24.20% |
| Decheng Capital LLC | 869,790 | $16,421,635 | 2.20% |
| Boxer Capital, LLC | 1,602,200 | $30,249,536 | 1.49% |
| DAFNA Capital Management LLC | 231,717 | $4,374,817 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 93,635 | $1,767,829 | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 957,304 | $18,073,900 | 0.67% |
| Parkman Healthcare Partners LLC | 259,920 | $4,907,290 | 0.60% |
| Woodline Partners LP | 2,883,657 | $54,443,444 | 0.50% |
| Granahan Investment Management | 296,570 | $5,599,242 | 0.20% |
| PDT Partners, LLC | 97,152 | $1,834,230 | 0.17% |